《美股业绩》亿滋国际季绩胜预期 市後升3%
生产Oreo曲奇、吉伯利及Milka朱古力等零食的美国食品巨擘亿滋国际(Mondelez International)(MDLZ.US)公布首季业绩。季度纯利9.61亿美元,按年升30.6%。每股季度摊薄纯利68美仙,经调整後为77美仙,高於市场预期的69美仙。季度收入72.38亿美元,按年升7.9%,高於市场预期的70.2亿美元。毛利率41%,按年升4.5个百分点。
公司财务总监Luca Zaramella表示,因应糖、小麦及大豆等商品价格上涨,产品价格将逐步地上调,又指由於已就原材料进行对冲,通胀影响可控。
亿滋国际股价在延长交易时段升3%,报60.51美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.